載入...
Effects of the NK(1) Antagonist, Aprepitant, on Response to Oral and Intranasal Oxycodone in Prescription Opioid Abusers
Preclinical studies suggest that the NK(1) receptor may modulate the response to opioids, with NK(1) inactivation leading to decreased opioid reinforcement, tolerance and withdrawal. Aprepitant is a selective NK(1) antagonist currently marketed for clinical use as an anti-emetic. This 6-week inpatie...
Na minha lista:
| 發表在: | Addict Biol |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
2012
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4354863/ https://ncbi.nlm.nih.gov/pubmed/22260216 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1369-1600.2011.00419.x |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|